Akari Therapeutics Analyst Ratings
Benzinga Analyst RatingsDec 5, 2022 19:11
HC Wainwright & Co. Initiates Coverage On Akari Therapeutics With Buy Rating, Announces Price Target of $1.5
Benzinga Real-time NewsDec 5, 2022 19:10
Alliance Global Starts Akari Therapeutics at Buy With $4 Price Target
MT NewswiresNov 1, 2022 21:31
No Data